{
    "code": "56027181",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56027181",
    "time": "2022-07-15 05:29:01",
    "許可證字號": "衛部醫器輸字第027181號",
    "註銷狀態": "已註銷",
    "註銷日期": "111\/06\/22",
    "註銷理由": "許可證已逾有效期",
    "製造許可登錄編號": "QSD6683",
    "有效日期": "109\/03\/19",
    "發證日期": "104\/03\/19",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05602718104",
    "中文品名": "“凱杰” 人類KRAS基因突變檢驗試劑組",
    "英文品名": "“QIAGEN” therascreen KRAS RGQ PCR Kit",
    "效能": "本產品是一種即時螢光PCR檢驗試劑組，可配合Rotor-Gene Q MDx 5plex HRM或Rotor-Gene Q 5plex HRM儀器使用，本產品利用從甲醛固定-石蠟包埋的大腸癌組織中萃取DNA，檢驗人體KRAS基因的7個體細胞突變。本產品輔助臨床醫師鑑別未能從抗表皮生長因子受體(EGFR)治療(如帕尼單抗(panitumumab)或西妥昔單抗(cetuximab))中受益的結直腸癌患者。",
    "醫器規格": "870011。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620118K794  凱杰生物科技有限公司",
    "申請商地址": "臺北市中正區羅斯福路2段100號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "MGB9036000  QIAGEN Manchester Ltd",
            "製造廠廠址": "Skelton House, Lloyd Street North, Manchester, M15 6SH, United Kingdom",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560271810001-104-06-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027181&Seq=001&Type=9"
        },
        {
            "title": "560271810002-104-06-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56027181&Seq=001&Type=8"
        }
    ]
}